GO:0032044 | DSIF complex | 3.33% (4/120) | 8.59 | 0.0 | 0.0 |
GO:0036258 | multivesicular body assembly | 3.33% (4/120) | 8.62 | 0.0 | 0.0 |
GO:0070676 | intralumenal vesicle formation | 3.33% (4/120) | 8.62 | 0.0 | 0.0 |
GO:0036257 | multivesicular body organization | 3.33% (4/120) | 8.62 | 0.0 | 0.0 |
GO:0009889 | regulation of biosynthetic process | 17.5% (21/120) | 2.47 | 0.0 | 0.0 |
GO:0031326 | regulation of cellular biosynthetic process | 17.5% (21/120) | 2.47 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 17.5% (21/120) | 2.49 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 17.5% (21/120) | 2.36 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 17.5% (21/120) | 2.35 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 17.5% (21/120) | 2.5 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 17.5% (21/120) | 2.31 | 0.0 | 0.0 |
GO:0000813 | ESCRT I complex | 3.33% (4/120) | 7.86 | 0.0 | 0.0 |
GO:0051252 | regulation of RNA metabolic process | 14.17% (17/120) | 2.53 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 15.0% (18/120) | 2.37 | 0.0 | 0.0 |
GO:0031902 | late endosome membrane | 3.33% (4/120) | 7.41 | 0.0 | 0.0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 14.17% (17/120) | 2.47 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 15.0% (18/120) | 2.36 | 0.0 | 0.0 |
GO:2001141 | regulation of RNA biosynthetic process | 13.33% (16/120) | 2.51 | 0.0 | 1e-06 |
GO:0006355 | regulation of DNA-templated transcription | 13.33% (16/120) | 2.51 | 0.0 | 1e-06 |
GO:0050794 | regulation of cellular process | 19.17% (23/120) | 1.93 | 0.0 | 1e-06 |
GO:0050789 | regulation of biological process | 19.17% (23/120) | 1.86 | 0.0 | 2e-06 |
GO:0007032 | endosome organization | 3.33% (4/120) | 6.52 | 0.0 | 3e-06 |
GO:0006368 | transcription elongation by RNA polymerase II | 3.33% (4/120) | 6.44 | 0.0 | 3e-06 |
GO:0042221 | response to chemical | 6.67% (8/120) | 3.77 | 0.0 | 3e-06 |
GO:0036452 | ESCRT complex | 3.33% (4/120) | 6.4 | 0.0 | 3e-06 |
GO:0006354 | DNA-templated transcription elongation | 3.33% (4/120) | 6.37 | 0.0 | 3e-06 |
GO:0065007 | biological regulation | 19.17% (23/120) | 1.75 | 0.0 | 4e-06 |
GO:0006900 | vesicle budding from membrane | 3.33% (4/120) | 6.07 | 0.0 | 7e-06 |
GO:0005515 | protein binding | 21.67% (26/120) | 1.53 | 1e-06 | 1.1e-05 |
GO:0008023 | transcription elongation factor complex | 3.33% (4/120) | 5.68 | 1e-06 | 1.9e-05 |
GO:0006357 | regulation of transcription by RNA polymerase II | 6.67% (8/120) | 3.33 | 2e-06 | 2.2e-05 |
GO:0032784 | regulation of DNA-templated transcription elongation | 3.33% (4/120) | 5.57 | 2e-06 | 2.4e-05 |
GO:0009725 | response to hormone | 4.17% (5/120) | 4.49 | 3e-06 | 4.4e-05 |
GO:0009719 | response to endogenous stimulus | 4.17% (5/120) | 4.33 | 6e-06 | 7.4e-05 |
GO:0043130 | ubiquitin binding | 3.33% (4/120) | 5.07 | 7e-06 | 8.8e-05 |
GO:0070274 | RES complex | 1.67% (2/120) | 8.97 | 7e-06 | 8.8e-05 |
GO:0010008 | endosome membrane | 3.33% (4/120) | 5.02 | 8e-06 | 9.5e-05 |
GO:0032182 | ubiquitin-like protein binding | 3.33% (4/120) | 5.0 | 9e-06 | 9.8e-05 |
GO:0005488 | binding | 40.0% (48/120) | 0.83 | 1.4e-05 | 0.000153 |
GO:0017007 | protein-bilin linkage | 1.67% (2/120) | 8.38 | 1.7e-05 | 0.000177 |
GO:0017009 | protein-phycocyanobilin linkage | 1.67% (2/120) | 8.38 | 1.7e-05 | 0.000177 |
GO:0012506 | vesicle membrane | 3.33% (4/120) | 4.73 | 1.8e-05 | 0.00018 |
GO:0030659 | cytoplasmic vesicle membrane | 3.33% (4/120) | 4.73 | 1.8e-05 | 0.00018 |
GO:0034599 | cellular response to oxidative stress | 2.5% (3/120) | 5.88 | 2e-05 | 0.000197 |
GO:0000302 | response to reactive oxygen species | 2.5% (3/120) | 5.87 | 2.1e-05 | 0.000197 |
GO:0062197 | cellular response to chemical stress | 2.5% (3/120) | 5.85 | 2.2e-05 | 0.000202 |
GO:0016050 | vesicle organization | 3.33% (4/120) | 4.62 | 2.4e-05 | 0.000217 |
GO:0017006 | protein-tetrapyrrole linkage | 1.67% (2/120) | 8.0 | 2.9e-05 | 0.000258 |
GO:0070925 | organelle assembly | 3.33% (4/120) | 4.26 | 6.3e-05 | 0.000544 |
GO:0010033 | response to organic substance | 4.17% (5/120) | 3.45 | 0.000105 | 0.00089 |
GO:0003676 | nucleic acid binding | 16.67% (20/120) | 1.34 | 0.00011 | 0.000919 |
GO:0042743 | hydrogen peroxide metabolic process | 2.5% (3/120) | 4.98 | 0.000129 | 0.001036 |
GO:0042744 | hydrogen peroxide catabolic process | 2.5% (3/120) | 4.98 | 0.000129 | 0.001036 |
GO:0070887 | cellular response to chemical stimulus | 2.5% (3/120) | 4.87 | 0.00016 | 0.001259 |
GO:0003674 | molecular_function | 51.67% (62/120) | 0.55 | 0.000183 | 0.001413 |
GO:0072593 | reactive oxygen species metabolic process | 2.5% (3/120) | 4.72 | 0.000221 | 0.001671 |
GO:0061024 | membrane organization | 3.33% (4/120) | 3.54 | 0.00042 | 0.003125 |
GO:0003729 | mRNA binding | 4.17% (5/120) | 2.89 | 0.000629 | 0.004519 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.0% (6/120) | 2.55 | 0.000626 | 0.004573 |
GO:0003677 | DNA binding | 9.17% (11/120) | 1.64 | 0.000881 | 0.006226 |
GO:1901700 | response to oxygen-containing compound | 2.5% (3/120) | 3.99 | 0.000955 | 0.006638 |
GO:0051254 | positive regulation of RNA metabolic process | 3.33% (4/120) | 3.16 | 0.001133 | 0.007749 |
GO:0008237 | metallopeptidase activity | 2.5% (3/120) | 3.89 | 0.001152 | 0.00775 |
GO:0008936 | nicotinamidase activity | 0.83% (1/120) | 9.7 | 0.001198 | 0.007934 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 2.5% (3/120) | 3.78 | 0.001446 | 0.009015 |
GO:0031267 | small GTPase binding | 1.67% (2/120) | 5.19 | 0.001427 | 0.009033 |
GO:0051020 | GTPase binding | 1.67% (2/120) | 5.19 | 0.001427 | 0.009033 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 3.33% (4/120) | 3.08 | 0.001385 | 0.009035 |
GO:0004176 | ATP-dependent peptidase activity | 1.67% (2/120) | 5.0 | 0.001866 | 0.0113 |
GO:0007030 | Golgi organization | 1.67% (2/120) | 5.0 | 0.001854 | 0.011393 |
GO:0018130 | heterocycle biosynthetic process | 5.0% (6/120) | 2.19 | 0.002218 | 0.013245 |
GO:0140513 | nuclear protein-containing complex | 5.83% (7/120) | 1.97 | 0.002252 | 0.013263 |
GO:0004601 | peroxidase activity | 2.5% (3/120) | 3.51 | 0.002453 | 0.013867 |
GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor | 2.5% (3/120) | 3.51 | 0.002453 | 0.013867 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 5.83% (7/120) | 1.94 | 0.002508 | 0.013993 |
GO:0032774 | RNA biosynthetic process | 3.33% (4/120) | 2.86 | 0.002412 | 0.014011 |
GO:0008150 | biological_process | 40.0% (48/120) | 0.52 | 0.002637 | 0.014519 |
GO:0031325 | positive regulation of cellular metabolic process | 3.33% (4/120) | 2.81 | 0.002728 | 0.014831 |
GO:0019438 | aromatic compound biosynthetic process | 5.0% (6/120) | 2.11 | 0.002841 | 0.015247 |
GO:0005840 | ribosome | 2.5% (3/120) | 3.33 | 0.003443 | 0.018249 |
GO:0006979 | response to oxidative stress | 2.5% (3/120) | 3.31 | 0.0036 | 0.018844 |
GO:0016209 | antioxidant activity | 2.5% (3/120) | 3.3 | 0.00366 | 0.018924 |
GO:0034249 | negative regulation of amide metabolic process | 1.67% (2/120) | 4.45 | 0.003899 | 0.019451 |
GO:0017148 | negative regulation of translation | 1.67% (2/120) | 4.45 | 0.003899 | 0.019451 |
GO:0032991 | protein-containing complex | 10.83% (13/120) | 1.23 | 0.003832 | 0.019577 |
GO:0043228 | non-membrane-bounded organelle | 5.0% (6/120) | 2.0 | 0.004139 | 0.020172 |
GO:0048522 | positive regulation of cellular process | 3.33% (4/120) | 2.63 | 0.004203 | 0.020253 |
GO:0043232 | intracellular non-membrane-bounded organelle | 5.0% (6/120) | 2.0 | 0.004137 | 0.020394 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 3.33% (4/120) | 2.61 | 0.004445 | 0.021177 |
GO:1901362 | organic cyclic compound biosynthetic process | 5.0% (6/120) | 1.96 | 0.00468 | 0.021336 |
GO:0016043 | cellular component organization | 7.5% (9/120) | 1.5 | 0.004765 | 0.021492 |
GO:0009893 | positive regulation of metabolic process | 3.33% (4/120) | 2.59 | 0.004667 | 0.021507 |
GO:0010604 | positive regulation of macromolecule metabolic process | 3.33% (4/120) | 2.59 | 0.004657 | 0.021698 |
GO:0005684 | U2-type spliceosomal complex | 1.67% (2/120) | 4.32 | 0.004641 | 0.021863 |
GO:1901006 | ubiquinone-6 biosynthetic process | 0.83% (1/120) | 7.54 | 0.005378 | 0.022355 |
GO:1901004 | ubiquinone-6 metabolic process | 0.83% (1/120) | 7.54 | 0.005378 | 0.022355 |
GO:0006338 | chromatin remodeling | 2.5% (3/120) | 3.13 | 0.005076 | 0.022656 |
GO:0005615 | extracellular space | 1.67% (2/120) | 4.25 | 0.005137 | 0.022688 |
GO:0016071 | mRNA metabolic process | 3.33% (4/120) | 2.53 | 0.005359 | 0.022723 |
GO:0003735 | structural constituent of ribosome | 2.5% (3/120) | 3.11 | 0.005316 | 0.022769 |
GO:0000932 | P-body | 1.67% (2/120) | 4.22 | 0.005308 | 0.022963 |
GO:0003723 | RNA binding | 6.67% (8/120) | 1.6 | 0.005265 | 0.023016 |
GO:0097159 | organic cyclic compound binding | 23.33% (28/120) | 0.7 | 0.005775 | 0.023771 |
GO:0005575 | cellular_component | 30.0% (36/120) | 0.59 | 0.005886 | 0.023996 |
GO:0004222 | metalloendopeptidase activity | 1.67% (2/120) | 4.12 | 0.006056 | 0.024455 |
GO:0006325 | chromatin organization | 2.5% (3/120) | 3.01 | 0.006428 | 0.025713 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67% (2/120) | 4.06 | 0.006615 | 0.025734 |
GO:0045893 | positive regulation of DNA-templated transcription | 2.5% (3/120) | 3.0 | 0.00658 | 0.025832 |
GO:1902680 | positive regulation of RNA biosynthetic process | 2.5% (3/120) | 3.0 | 0.00658 | 0.025832 |
GO:0035770 | ribonucleoprotein granule | 1.67% (2/120) | 4.03 | 0.006807 | 0.026238 |
GO:0051248 | negative regulation of protein metabolic process | 1.67% (2/120) | 3.99 | 0.007197 | 0.027493 |
GO:0006412 | translation | 2.5% (3/120) | 2.93 | 0.007451 | 0.027959 |
GO:0006996 | organelle organization | 5.0% (6/120) | 1.82 | 0.007397 | 0.028003 |
GO:0004181 | metallocarboxypeptidase activity | 0.83% (1/120) | 7.04 | 0.00756 | 0.02812 |
GO:0070012 | oligopeptidase activity | 0.83% (1/120) | 7.0 | 0.007759 | 0.028606 |
GO:0048518 | positive regulation of biological process | 3.33% (4/120) | 2.37 | 0.007869 | 0.028763 |
GO:0044248 | cellular catabolic process | 4.17% (5/120) | 2.03 | 0.008043 | 0.029149 |
GO:0040029 | epigenetic regulation of gene expression | 1.67% (2/120) | 3.79 | 0.009421 | 0.032742 |
GO:0016070 | RNA metabolic process | 6.67% (8/120) | 1.46 | 0.009168 | 0.032942 |
GO:0043043 | peptide biosynthetic process | 2.5% (3/120) | 2.8 | 0.009414 | 0.03299 |
GO:0071840 | cellular component organization or biogenesis | 7.5% (9/120) | 1.35 | 0.00941 | 0.033248 |
GO:0098588 | bounding membrane of organelle | 3.33% (4/120) | 2.3 | 0.00936 | 0.03335 |
GO:0010048 | vernalization response | 0.83% (1/120) | 6.68 | 0.009738 | 0.03357 |
GO:0098796 | membrane protein complex | 3.33% (4/120) | 2.25 | 0.010314 | 0.035267 |
GO:0019365 | pyridine nucleotide salvage | 0.83% (1/120) | 6.56 | 0.010529 | 0.035715 |
GO:0140673 | transcription elongation-coupled chromatin remodeling | 0.83% (1/120) | 6.51 | 0.010924 | 0.036762 |
GO:0009891 | positive regulation of biosynthetic process | 2.5% (3/120) | 2.7 | 0.011387 | 0.037427 |
GO:0031328 | positive regulation of cellular biosynthetic process | 2.5% (3/120) | 2.7 | 0.011387 | 0.037427 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 2.5% (3/120) | 2.7 | 0.011387 | 0.037427 |
GO:0071824 | protein-DNA complex organization | 2.5% (3/120) | 2.68 | 0.011827 | 0.038573 |
GO:0004594 | pantothenate kinase activity | 0.83% (1/120) | 6.2 | 0.013489 | 0.04366 |
GO:0010629 | negative regulation of gene expression | 2.5% (3/120) | 2.61 | 0.013624 | 0.043762 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.67% (2/120) | 3.5 | 0.013732 | 0.043776 |
GO:0006417 | regulation of translation | 1.67% (2/120) | 3.47 | 0.014294 | 0.044894 |
GO:0034248 | regulation of amide metabolic process | 1.67% (2/120) | 3.47 | 0.014294 | 0.044894 |
GO:0006518 | peptide metabolic process | 2.5% (3/120) | 2.55 | 0.0151 | 0.047075 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 0.83% (1/120) | 6.0 | 0.015458 | 0.04784 |
GO:0110165 | cellular anatomical entity | 25.83% (31/120) | 0.55 | 0.016136 | 0.049577 |